China Concludes First-Ever Securities Class Action With a Slap-on-the-Wrist Order

November 22, 2021 | BY

Jessica Seah

In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.

Share:

Map of China and a hand Credit: vegefox.com/Adobe Stock

(This article was first published on Law.com International.)

Kangmei Pharmaceuticals, one of China's largest Chinese medicine makers, has been ordered to pay its 50,000 investors $385 million as compensation for